SCHEMBL6424653

SCHEMBL6424653

NC(=O)c1cccc(CC(=O)c2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
PARP1 P09874 2/20 0.52
POLB P06746 1/20 0.52
CYP3A4 P08684 1/20 0.52
TSHR P16473 1/20 0.52
CYP2C19 P33261 1/20 0.52
RECQL P46063 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
HSD17B10 Q99714 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
FOLH1 Q04609 1/20 0.51
SRD5A2 P31213 2/20 0.50
PLAU P00749 2/20 0.50
STS P08842 1/20 0.50
PLA2G10 O15496 1/20 0.50
PLA2G2A P14555 1/20 0.50
SLC6A4 P31645 1/20 0.49
KDM1A O60341 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11633589 0.87 MAPT (0.60) MAPTL3MBTL1CYP3A4TDP1SRD5A2
SCHEMBL2426602 0.85 AKR1B1 (0.54) MAPTL3MBTL1PARP1POLBCYP3A4
SCHEMBL13381372 0.85 SRD5A2 (0.62) MAPTL3MBTL1FOLH1SRD5A2ANPEP
SCHEMBL3054667 0.83 PARP1 (0.53) MAPTL3MBTL1PARP1POLBCYP3A4
SCHEMBL9379028 0.82 PBRM1 (0.55) MAPTL3MBTL1CYP3A4TDP1SRD5A2
SCHEMBL27625881 0.82 LOXL2 (0.51) MAPTL3MBTL1CYP3A4TSHRCYP2C19
SCHEMBL2978267 0.81 PLA2G10 (0.63) MAPTL3MBTL1PARP1POLBCYP3A4
SCHEMBL10189495 0.81 PARP1 (0.56) MAPTL3MBTL1PARP1POLBCYP3A4
SCHEMBL7475229 0.81 AKR1B1 (0.59) MAPTL3MBTL1CYP3A4TSHRCYP2C19
SCHEMBL4224616 0.81 PLA2G2A (0.69) MAPTL3MBTL1PARP1POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 MAPT 4512/4885L3MBTL1 1261/4885PARP1 3139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.